Process Design

OUR STRATEGY

Our strategy is to leverage our expertise in organocatalysis to design and develop robust, scalable, green processes to make high-value advanced intermediates and API’s for well-known drugs. 

 

Our suite of organocatalysts are cheap, selective, scalable and recyclable; and do not use expensive precious metals.

Typical process characteristics include:

  • High yields

  • No temperature or pressure extremes required

  • All solvents class 2 or 3

  • E-factor of between 10 and 15

OUR SUCCESS

Notable successes include our processes for advanced intermediates of the following drugs – typically yielding a 60-80% reduction in Raw Material Costs:

 

  • Pregabalin

  • Atomoxetine

  • Duloxetine

  • Montelukast

We also actively engage on projects with the Pharmaceutical and Fine Chemical communities to target other high value intermediates via organocatalysis.

Please contact us with any queries

KelAda Pharmachem Limited.

Established in the Republic of Ireland. 

Company Registration Number 513259.

  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon